← Back
Data updated: Mar 10, 2026
ALNYLAM PHARMS INC
Gastroenterology
ALNYLAM PHARMS INC is a pharmaceutical company focused on Gastroenterology. Key products include AMVUTTRA.
2018
Since
4
Drugs
-
Trials
4
Approved (2yr)
Key Drugs
Recent Activity
OXLUMO 2025-04-04
Labeling
AMVUTTRA 2025-03-20
Efficacy
AMVUTTRA 2025-03-11
Labeling
GIVLAARI 2024-04-29
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Gastroenterology 100%
1 drugs
Pipeline Strength Pro
Loading...